In pediatric symptomatic bradycardia with poor perfusion, atropine is used to counteract excessive vagal (parasympathetic) influence on the heart, helping the heart rate rise quickly to improve perfusion. The recommended approach is a dose of 0.02 mg/kg given IV or IO, with a minimum dose of 0.1 mg to ensure a detectable amount in smaller children and a maximum of 0.5 mg per dose to prevent excessive anticholinergic effects. If perfusion remains compromised and the rhythm persists, repeating the same dose every 3–5 minutes is acceptable, up to the per-dose maximum. This dosing targets rapid vagal relief and is specific to pediatric bradycardia where atropine is indicated; smaller or larger per-dose amounts are not aligned with the guideline, and there are scenarios where atropine may not be effective, requiring other interventions.

After resuscitation, the goal is to minimize brain injury and other organ damage by supporting all critical body systems affected by the arrest. This means ensuring good oxygenation and ventilation to optimize respiratory function, maintaining stable cardiovascular status to preserve cerebral perfusion, and actively protecting the brain through neurologic assessment and targeted therapies. It also involves treating underlying causes, controlling temperature, glucose, and hemodynamics, and preventing secondary complications. Because post-cardiac arrest care is a coordinated, multi-system effort, the objective described—reducing morbidity and mortality by assessing and managing the respiratory, cardiovascular, and neurologic systems—best captures the overall aim. The other options focus on only one aspect (circulation, pain, or arrhythmia prevention) and miss the SAMPLEcomprehensive, multi-system approach essential to improving outcomes.

In pediatric symptomatic bradycardia, atropine is dosed by weight and given IV or IO to quickly counteract excessive vagal tone on the heart. The standard approach is 0.02 mg/kg per dose, with a minimum of 0.1 mg and a maximum of 0.5 mg per dose. This keeps the dose effective across different child sizes while limiting the risk of anticholinergic toxicity. The 0.02 mg/kg amount is the amount most likely to raise the heart rate when bradycardia is due to vagal stimulation, which is a common reversible cause in children. The minimum ensures even very small patients receive a measurable dose, while the maximum prevents too much atropine, which can cause overheating, delirium, tachyarrhythmias, or paradoxical bradycardia at high levels. If atropine doesn’t improve the rhythm, other interventions such as pacing or an epinephrine infusion are considered.

In pediatric CPR, how deep you push down should scale with the size of the chest. The guideline is to depress the chest about one-third of the chest’s anterior-posterior (front-to-back) diameter. This proportion keeps the heart compressed enough to generate blood flow without causing excessive injury, and it naturally accommodates the wide range of chest sizes from infants to larger children. For example, a small infant’s chest AP diameter is narrower, so about a 1.5–4 cm depth corresponds to one-third of that diameter. In an older child, the same fraction translates to a larger actual depth, around 5 cm or so. It’s also important to allow full chest recoil between compressions to maximize venous return, but that recoil is separate from the depth guideline.